The Problem of Limited-Supply Agreements for Medicare Price Negotiation.
JAMA
; 330(13): 1223-1224, 2023 10 03.
Article
in En
| MEDLINE
| ID: mdl-37713185
This Viewpoint discusses how limited-supply agreements (introduction of generic products in reduced volumes) might thwart efforts to negotiate lower prices on prescription drugs in the US.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pharmaceutical Preparations
/
Medicare
/
Negotiating
/
Drug Costs
/
Drug Industry
Type of study:
Health_economic_evaluation
Limits:
Aged
/
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
JAMA
Year:
2023
Document type:
Article
Country of publication: